Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV.

Ford N, Hirnschall G.

PLoS Med. 2013 Oct;10(10):e1001535. doi: 10.1371/journal.pmed.1001535. Epub 2013 Oct 22.

2.

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.

Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, Garnett GP, Hallett TB.

PLoS Med. 2012;9(10):e1001323. doi: 10.1371/journal.pmed.1001323. Epub 2012 Oct 9.

3.

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.

Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R; ARROW Trial Team.

PLoS Med. 2013 Oct;10(10):e1001542. doi: 10.1371/journal.pmed.1001542. Epub 2013 Oct 29.

4.

Male circumcision at different ages in Rwanda: a cost-effectiveness study.

Binagwaho A, Pegurri E, Muita J, Bertozzi S.

PLoS Med. 2010 Jan 19;7(1):e1000211. doi: 10.1371/journal.pmed.1000211.

5.

Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Review.

PMID:
18646068
7.

Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.

Over M, Marseille E, Sudhakar K, Gold J, Gupta I, Indrayan A, Hira S, Nagelkerke N, Rao AS, Heywood P.

Sex Transm Dis. 2006 Oct;33(10 Suppl):S145-52.

PMID:
17003679
8.

Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.

Forsyth AD, Valdiserri RO.

Curr Opin HIV AIDS. 2012 Mar;7(2):111-6. doi: 10.1097/COH.0b013e32834fcff6. Review.

PMID:
22227586
9.

Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention.

Hull MW, Wu Z, Montaner JS.

Curr Opin HIV AIDS. 2012 Nov;7(6):579-86. doi: 10.1097/COH.0b013e3283590617. Review.

PMID:
23076123
10.

A model for the roll-out of comprehensive adult male circumcision services in African low-income settings of high HIV incidence: the ANRS 12126 Bophelo Pele Project.

Lissouba P, Taljaard D, Rech D, Doyle S, Shabangu D, Nhlapo C, Otchere-Darko J, Mashigo T, Matson C, Lewis D, Billy S, Auvert B.

PLoS Med. 2010 Jul 20;7(7):e1000309. doi: 10.1371/journal.pmed.1000309.

11.

PEPFAR, health system strengthening, and promoting sustainability and country ownership.

Palen J, El-Sadr W, Phoya A, Imtiaz R, Einterz R, Quain E, Blandford J, Bouey P, Lion A.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S113-9. doi: 10.1097/QAI.0b013e31825d28d7. Review.

PMID:
22797732
12.

Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.

Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD009153. doi: 10.1002/14651858.CD009153.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD009153.

PMID:
21833973
13.

Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.

Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR.

Curr Opin HIV AIDS. 2012 Jul;7(4):362-8. doi: 10.1097/COH.0b013e328354a0b5. Review.

PMID:
22647588
14.

Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus.

Blocker ME, Cohen MS.

Infect Dis Clin North Am. 2000 Dec;14(4):983-99. Review.

PMID:
11144648
15.

Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors.

Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):455-63. doi: 10.1097/QAI.0b013e3182a61e8d.

PMID:
23892242
16.

Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.

Dieffenbach CW.

Curr Opin HIV AIDS. 2012 Mar;7(2):106-10. doi: 10.1097/COH.0b013e32834f3f13. Review.

PMID:
22227584
17.

Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.

Anglemyer A, Rutherford GW, Egger M, Siegfried N.

Cochrane Database Syst Rev. 2011 May 11;(5):CD009153. doi: 10.1002/14651858.CD009153. Review. Update in: Cochrane Database Syst Rev. 2011;(8):CD009153.

PMID:
21563172
18.

Fifteen million people on antiretroviral treatment by 2015: treatment as prevention.

Granich R, Williams B, Montaner J.

Curr Opin HIV AIDS. 2013 Jan;8(1):41-9. doi: 10.1097/COH.0b013e32835b80dd. Review.

PMID:
23188178
19.
20.

The role of testing and counselling for HIV prevention and care in the era of scaling-up antiretroviral therapy.

Hallett TB, Dube S, Cremin I, Lopman B, Mahomva A, Ncube G, Mugurungi O, Gregson S, Garnett GP; Testing and Counselling Mathematical Modelling Group.

Epidemics. 2009 Jun;1(2):77-82. doi: 10.1016/j.epidem.2009.02.001. Epub 2009 Mar 17.

PMID:
21352753

Supplemental Content

Support Center